Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 441931
Gene Symbol: VN1R17P
VN1R17P
0.010 GeneticVariation disease BEFREE Our study reveals a low prevalence of GPCR-mediated PI3K pathway mutations both in pediatric and adult DTCs corroborating the TCGA data and suggests a significant role of this pathway only in a small portion of DTCs. 31289610 2019
Entrez Id: 407007
Gene Symbol: MIR222
MIR222
0.010 AlteredExpression disease BEFREE Elevated miR-222 and miR-146 levels are associated with poorer outcomes of the disease and may have a prognostic value in the management and follow-up of DTC. 30887564 2019
Entrez Id: 1471
Gene Symbol: CST3
CST3
0.010 Biomarker disease BEFREE Determination of effective half-life of <sup>131</sup>I in patients with differentiated thyroid carcinoma: comparison of cystatin C and creatinine-based estimation of renal function. 30382554 2019
Entrez Id: 4359
Gene Symbol: MPZ
MPZ
0.010 Biomarker disease BEFREE Although extent of thyroidectomy does not affect DSS, total thyroidectomy is beneficial for reducing recurrence in patients with 1-cm to 4-cm DTC. 30536465 2019
Entrez Id: 5376
Gene Symbol: PMP22
PMP22
0.010 Biomarker disease BEFREE Although extent of thyroidectomy does not affect DSS, total thyroidectomy is beneficial for reducing recurrence in patients with 1-cm to 4-cm DTC. 30536465 2019
Entrez Id: 442206
Gene Symbol: GPR166P
GPR166P
0.010 GeneticVariation disease BEFREE Our study reveals a low prevalence of GPCR-mediated PI3K pathway mutations both in pediatric and adult DTCs corroborating the TCGA data and suggests a significant role of this pathway only in a small portion of DTCs. 31289610 2019
Entrez Id: 80380
Gene Symbol: PDCD1LG2
PDCD1LG2
0.010 Biomarker disease BEFREE ATC = anaplastic thyroid cancer; DTC = differentiated thyroid cancer; IHC = immunohistochemical; OS = overall survival; PD-1 = programmed cell death-receptor 1; PD-L1 = programmed cell death-ligand 1; PD-L2 = programmed cell death-ligand 2; PTC = papillary thyroid cancer; TNM = tumor-node-metastasis; Treg = regulatory T cell. 30913016 2019
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.010 Biomarker disease BEFREE As excess weight is a state of chronic inflammation, we investigated the relationship between concentrations of leptin, adiponectin, C-reactive protein, interleukin (IL)-6, IL-10 and tumor necrosis factor (TNF)-α and the risk of TC. 29168186 2018
Entrez Id: 7792
Gene Symbol: CCV
CCV
0.010 Biomarker disease BEFREE The clinicopathologic characteristics of CCV-PTC and the paraneoplastic syndromes in follicular cell differentiated thyroid carcinoma were further summarized using literature review. 29446856 2018
Entrez Id: 1831
Gene Symbol: TSC22D3
TSC22D3
0.010 AlteredExpression disease BEFREE L-GILZ protein was highly expressed in well-differentiated cancer cells from thyroid cancer patients and differentiated thyroid cancer cell lines, but poorly expressed in anaplastic tumors. 29467389 2018
Entrez Id: 2146
Gene Symbol: EZH2
EZH2
0.010 AlteredExpression disease BEFREE We examined EZH2 protein expression by immunohistochemistry in tissue samples from 67 cases of poorly differentiated (PDTC) and 48 cases of anaplastic thyroid carcinoma (ATC), and in samples of adjacent normal and differentiated thyroid carcinoma (DTC). 29275295 2018
Entrez Id: 6692
Gene Symbol: SPINT1
SPINT1
0.010 AlteredExpression disease BEFREE Furthermore, we noted that the SPINT1 expression was associated with extrathyroidal invasion, lymphovascular invasion, lymph node metastasis, advanced TNM stage, and a higher risk of recurrence in differentiated thyroid cancer. 29532159 2018
Entrez Id: 192
Gene Symbol: AIC
AIC
0.010 Biomarker disease BEFREE The highest C-index value (0.933) and the lowest AIC value (9362.687) obtained indicated that the PLNN better predicted the CSS of DTC than did the LNR or LNE. 29185020 2018
Entrez Id: 84525
Gene Symbol: HOPX
HOPX
0.010 PosttranslationalModification disease BEFREE A moderate coupling of downregulation of HOPX-β mRNA expression in DTC followed by high HOPX-β promoter methylation was observed however; high HOPX promoter methylation status was associated with the worse prognosis of DTC patients. 30400039 2018
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 Biomarker disease BEFREE Leptin, CRP, IL-6 and TNF-α were not associated with TC risk in either gender. 29168186 2018
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.010 AlteredExpression disease BEFREE Concentrations of plasma lipids and apolipoproteins, paraoxonase-1 activity, and cholesterol efflux were measured in 27 patients with differentiated thyroid carcinoma who underwent total thyroidectomy and radioactive iodine (RAI) treatment, at 3 distinct times: After surgery (baseline subclinical hyperthyroid state), on the day of undergoing RAI treatment (overt hypothyroid state), and 3 months post-RAI treatment (subclinical hyperthyroid state). 28958565 2018
Entrez Id: 7037
Gene Symbol: TFRC
TFRC
0.010 Biomarker disease BEFREE Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. 30584304 2018
Entrez Id: 2309
Gene Symbol: FOXO3
FOXO3
0.010 Biomarker disease BEFREE Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer. 30271381 2018
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
0.010 Biomarker disease BEFREE Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer. 28779086 2017
Entrez Id: 5328
Gene Symbol: PLAU
PLAU
0.010 AlteredExpression disease BEFREE When PATZ1 was silenced in differentiated thyroid cancer (DTC) cell lines (TPC-1 and FTC-133), proliferation, cellular motility, and expression of uPA and MMPs were significantly increased. 29137300 2017
Entrez Id: 128869
Gene Symbol: PIGU
PIGU
0.010 Biomarker disease BEFREE We used a multivariable logistic regression model to study the role of PIGU in the response to RAI treatment in advanced DTC.All statistical tests were two-sided. 30053080 2017
Entrez Id: 205717
Gene Symbol: USF3
USF3
0.010 GeneticVariation disease BEFREE To identify additional candidate genes of CS and potentially DTC, we analysed a multi-generation CS-like family with papillary thyroid cancer (PTC), applying a combined linkage-based and whole-genome sequencing strategy and identified an in-frame germline compound heterozygous deletion, p.[Gln1478del];[Gln1476-Gln1478del] in USF3 (previously known as KIAA2018). 28011713 2017
Entrez Id: 55366
Gene Symbol: LGR4
LGR4
0.010 Biomarker disease BEFREE Our findings demonstrate that upregulation of the R-spondin 2-GPR48/LGR4 pathway contributes to tumor aggressiveness in papillary thyroid carcinoma by promoting ERK phosphorylation, suggesting that this pathway represents a novel therapeutic target for treatment of differentiated thyroid cancer. 29383135 2017
Entrez Id: 1493
Gene Symbol: CTLA4
CTLA4
0.010 GeneticVariation disease BEFREE CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma. 28326838 2017
Entrez Id: 23598
Gene Symbol: PATZ1
PATZ1
0.010 Biomarker disease BEFREE When PATZ1 was silenced in differentiated thyroid cancer (DTC) cell lines (TPC-1 and FTC-133), proliferation, cellular motility, and expression of uPA and MMPs were significantly increased. 29137300 2017